These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2827077)

  • 21. Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine.
    Sharma A; Kaur P; Kumar V; Gill KD
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):48-55. PubMed ID: 17519111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine content in young and mature mice.
    Saitoh T; Niijima K; Mizuno Y
    J Neurol Sci; 1987 Feb; 77(2-3):229-35. PubMed ID: 3493330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content.
    Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu I; Nagatsu T
    Neurosci Lett; 1987 Sep; 80(2):213-8. PubMed ID: 2891089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c mice.
    Samantaray S; Mohanakumar KP
    Neurosci Lett; 2003 Jul; 346(1-2):69-72. PubMed ID: 12850550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Difference in recovery patterns of striatal dopamine content, tyrosine hydroxylase activity and total biopterin content after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration: a comparison of young and older mice.
    Nishi K; Kondo T; Narabayashi H
    Brain Res; 1989 Jun; 489(1):157-62. PubMed ID: 2568151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of gender and estrogen on striatal dopaminergic neurotoxicity.
    Miller DB; Ali SF; O'Callaghan JP; Laws SC
    Ann N Y Acad Sci; 1998 May; 844():153-65. PubMed ID: 9668673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphetamine, but not reserpine, protects mice against dopaminergic neurotoxicity of MPTP.
    Melamed E; Rosenthal J; Cohen O; Uzzan A; Globus M
    Neuropharmacology; 1985 Sep; 24(9):923-5. PubMed ID: 3877249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat.
    Matsuda LA; Schmidt CJ; Hanson GR; Gibb JW
    Neuropharmacology; 1986 Mar; 25(3):249-55. PubMed ID: 2871513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Lau YS; Trobough KL; Crampton JM; Wilson JA
    Gen Pharmacol; 1990; 21(2):181-7. PubMed ID: 2332138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased striatal dopamine turnover following acute administration of rotenone to mice.
    Thiffault C; Langston JW; Di Monte DA
    Brain Res; 2000 Dec; 885(2):283-8. PubMed ID: 11102582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early and late effects of systemically administered 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on tyrosine hydroxylase activity in vitro and on tyrosine hydroxylation in tissue slices of mouse striatum.
    Hirata Y; Nagatsu T
    Neurosci Lett; 1986 Jul; 68(2):245-8. PubMed ID: 2875421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
    Zuddas A; Fascetti F; Corsini GU; Piccardi MP
    Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Lau YS; Fung YK; Trobough KL; Cashman JR; Wilson JA
    Neurotoxicology; 1991; 12(2):189-99. PubMed ID: 1956580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
    D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
    Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
    Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
    Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
    Moy LY; Albers DS; Sonsalla PK
    Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies.
    Manaye KF; Sonsalla PK; Barnett G; Heikkila RE; Woodward DJ; Smith WK; German DC
    Brain Res; 1989 Jul; 491(2):307-15. PubMed ID: 2765888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphological, neurochemical, and behavioral characterizations associated with the combined treatment of diethyldithiocarbamate and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Yurek DM; Deutch AY; Roth RH; Sladek JR
    Brain Res; 1989 Sep; 497(2):250-9. PubMed ID: 2573405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions.
    Fornai F; Alessandrì MG; Torracca MT; Bassi L; Corsini GU
    J Pharmacol Exp Ther; 1997 Oct; 283(1):100-7. PubMed ID: 9336313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.
    Mitsumoto Y; Mori A
    Neurosci Bull; 2018 Oct; 34(5):849-853. PubMed ID: 29987518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.